Literature DB >> 7035526

Dermal hypersensitivity reactions to insulin: correlations of three patterns to their histopathology.

R D deShazo, T M Boehm, D Kumar, J A Galloway, H F Dvorak.   

Abstract

Fifteen diabetics with recurrent painful local reactions to insulin were studied. Reactions occurring after intradermal insulin injection were observed in nine patients over 48 hr and biopsies were taken at intervals for microscopic study using the 1 mu Giemsa technique. Insulin-specific IgE and IgG levels were measured on all patients. Five patients had biphasic reactions in which wheal and flare (WFR) were followed by an indurated lesion 4 to 6 hr later. These reactions lasted up to 24 hr and were histopathologically identical to similar "late-phase reactions" seen with ragweed. They were transferable with Prausnitz-Küstner (P-K) testing. Three patients had reactions that developed 8 to 12 hr after injection, peaked around 24 hr, and were not preceded by WFR. These reactions were morphologically delayed hypersensitivity reactions and were not transferred by P-K testing. One patient had a reaction that developed in 4 to 6 hr after injection and peaked by 12 hr. Histologically, this reaction was "Arthus" in type and was not transferred by P-K testing. Specific insulin antibody determinations were not helpful in distinguishing patients with different types of reactivity. These data show that recurrent local reactions to insulin may be of three distinct types: "late-phase reactions" (which are IgE dependent), "Arthus" local vasculitic reactions, or tuberculin-type delayed hypersensitivity reactions. These findings may influence the approach to management of these reactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7035526     DOI: 10.1016/0091-6749(82)90104-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

Review 1.  Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.

Authors:  Anneke Graf; Sybil A McAuley; Catriona Sims; Johanna Ulloa; Alicia J Jenkins; Gayane Voskanyan; David N O'Neal
Journal:  J Diabetes Sci Technol       Date:  2016-12-13

2.  Generalised allergic reaction to human insulin.

Authors:  P Silverstone
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

Review 3.  Insulin allergy.

Authors:  L Grammer
Journal:  Clin Rev Allergy       Date:  1986-05

4.  Type III Hypersensitivity Reaction to Subcutaneous Insulin Preparations in a Type 1 Diabetic.

Authors:  Benjamin R Murray; Jolene R Jewell; Kyle J Jackson; Olabunmi Agboola; Brianna R Alexander; Poonam Sharma
Journal:  J Gen Intern Med       Date:  2017-03-23       Impact factor: 5.128

5.  The human cellular immune response to insulin: a study in unexposed control subjects and type I diabetic patients on acute and chronic treatment.

Authors:  E R Richens; M E Seward; W A Luqman; M Hartog
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

Review 6.  Allergic reactions to human insulin: a review of current knowledge and treatment options.

Authors:  Baris Akinci; Serkan Yener; Firat Bayraktar; Sena Yesil
Journal:  Endocrine       Date:  2009-10-30       Impact factor: 3.633

7.  Hypersensitivity reaction associated with subcutaneous glargine insulin therapy in a cat.

Authors:  Lisa A Murphy; Greg F Zuendt; Reid K Nakamura; Paul Gambardella
Journal:  JFMS Open Rep       Date:  2016-11-14

8.  Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.

Authors:  Chao Wang; Ninghua Huang; Qing-Bin Lu; Steven Black; Xiaofeng Liang; Fuqiang Cui
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

9.  The complexities of insulin allergy: a case and approach.

Authors:  Babak Aberumand; Samira Jeimy
Journal:  Allergy Asthma Clin Immunol       Date:  2021-07-29       Impact factor: 3.406

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.